EU revives GMP for excipients

By Nick Taylor

- Last updated on GMT

Related tags: Excipients, Active ingredient

The EFCG has welcomed the addition of excipient GMP requirements to the draft amendments of the EU falsified medicines directive but warned that deeper analysis is needed to establish which products warrant further regulation.

A directive to establish good manufacturing practices (GMP) for certain excipients was dropped by the European Commission (EC) last year following concerns about the inflexibility of the proposal.

The issue is now back on the agenda after a draft opinion from the Committee on the Environment, Public Health and Food Safety (ENVI), the lead group for the anti-counterfeiting directive, proposed GMP requirements for excipients.

Broadly speaking this is a positive development, according to Alexandra Brand, a board member of the European Fine Chemicals Group (EFCG). Speaking to in-PharmaTechnologist Brand said that “patient safety is paramount​” and excipient quality is an important aspect of ensuring this.

However, the legislation must reflect the risk, added Brand. Some excipients are already appropriately regulated, according to Brand, and consequently GMP legislation covering all products “would hammer on everyone when you only need to hit specific nails​”.

To avoid this overlap in legislation, and the subsequent burden on excipient manufacturers, Brand is calling for a “deeper analysis​” of the situation. This would identify which excipients need further legislation, such as those not covered by suitable food regulations.

Furthermore, GMP legislation covering excipients should differ from active pharmaceutical ingredients (API) regulations, Brand added. Again, this is to ensure that legislation ensures patient safety without subjecting excipient manufacturers to unnecessary burdens.

Currently, ENVI’s draft opinion appears to lack these stipulations. It states: “The manufacture of APIs or excipients​should be subject to GMP irrespective of whether those ingredients or excipients​were manufactured in the community or imported​.”

The EFCG, and parent organisation the European Chemical Industry Council (Cefic), are now pushing to ensure the legislation takes its concerns into account. Currently, the EFCG believes a final vote on the legislation is likely to occur in June.


The draft opinion also states that routine or unannounced inspections of excipient manufacturers, importers or distributors should be conducted whenever there is a suspicion of non-compliance with GMP. This also covers unannounced inspections of sites outside the EU.

It is unclear if the final legislation will enforce mandatory inspections, with some questioning if there are sufficient resources. Regardless, the EFCG, in conjunction with groups including the International Pharmaceutical Excipients Council (IPEC), is pushing ahead with self-regulation.

The scheme would use third-party auditors to assess if excipient suppliers are in compliance with the certification standard the trade bodies have formulated. Brand hopes to have the programme in operation by the end of 2010.

Related news

Show more

Related products

show more

How to resolve sticking issues in tablet production

How to resolve sticking issues in tablet production

I Holland Limited - Tabletting Science | 24-Jun-2019 | Case Study

Tablet sticking is one of the most common problems in tablet manufacture. Find out how I Holland used the TSAR scientific predictive model and expert tablet...

How to measure powder and granule flow properties

How to measure powder and granule flow properties

Stable Micro Systems | 01-Apr-2019 | Technical / White Paper

Being able to predict, optimise and control powder flow is of prime importance to manufacturers in ensuring high quality standards. Download this free...

Accelerate your supply chain as pressures intensify

Accelerate your supply chain as pressures intensify

William Reed | 17-Sep-2018 | Technical / White Paper

Food, Drink and Non-Food manufacturers are under pressure. Range reviews, massive retail mergers, the backlash against plastic packaging and the ongoing...

Related suppliers


Commitment to GMP

Posted by Professor Mohamed Etman,

It is good to enforce GMP for excepients and it might be a late decision but it is not a matter of issuing new guidelines rather than commitment of producers to the regulation. We must not forget the crises of Heparin that happened with one of the top ranking pharmaceutical products manufacturers. The issue with excepients is sometimes more serious than with drugs, they are usually taken in greater quantities that might constitute a greater risk to consumers if their quality is not guranteed

Report abuse

@jamal mohamed

Posted by Nick Taylor,

Thanks for your comment Jamal. My understanding is that in Europe control of excipients is achieved through directives applying to the finished product. Background information on the topic can be found in our archive:

Report abuse


Posted by jamal mohamed,

cGMP pricipal for excipients is mandatory

Report abuse

Follow us


View more